Optiver Holding’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$796K Buy
+26,535
New +$879K ﹤0.01% 582
2025
Q3
Sell
-78,929
Closed -$2.21M 2773
2025
Q2
$2.21M Buy
78,929
+48,521
+160% +$1.3M ﹤0.01% 267
2025
Q1
$764K Buy
+30,408
New +$768K ﹤0.01% 311
2024
Q4
Sell
-69,396
Closed -$2M 1097
2024
Q3
$2M Buy
69,396
+61,448
+773% +$1.67M ﹤0.01% 355
2024
Q2
$197K Buy
7,948
+5,912
+290% +$168K ﹤0.01% 491
2024
Q1
$65.6K Sell
2,036
-47,924
-96% -$1.78M ﹤0.01% 531
2023
Q4
$2.03M Buy
+49,960
New +$1.84M ﹤0.01% 347
2023
Q2
Sell
-2,246
Closed -$91.6K 522
2023
Q1
$86.8K Sell
2,246
-34,460
-94% -$1.42M ﹤0.01% 415
2022
Q4
$1.63M Sell
36,706
-67,407
-65% -$2.84M ﹤0.01% 309
2022
Q3
$4.44M Sell
104,113
-207,440
-67% -$10.6M ﹤0.01% 209
2022
Q2
$17.4M Buy
311,553
+300,094
+2,619% +$17.8M 0.02% 131
2022
Q1
$711K Sell
11,459
-20,747
-64% -$1.27M ﹤0.01% 227
2021
Q4
$1.71M Buy
32,206
+6,149
+24% +$321K ﹤0.01% 223
2021
Q3
$1.37M Buy
26,057
+11,336
+77% +$673K ﹤0.01% 199
2021
Q2
$1.01M Buy
+14,721
New +$1.12M ﹤0.01% 189

Other funds holding LKFT

Optiver Holding's LKFT Position: Q1 2026 in Review

Optiver Holding opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026: 26,535 shares worth $796K. The stake represents ﹤0.01% of the portfolio and ranks #582 among its holdings. This is a return to the name: Optiver Holding previously reported a position in LKFT as recently as Q2 2025.

Optiver Holding first reported a position in LKFT in Q2 2021 and has held it in 15 quarters since. The position peaked at $17.4M in Q2 2022. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Optiver Holding held 26,535 shares of Lakefront Biotherapeutics American Depositary Shares worth $796K as of Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares was a new Optiver Holding position in Q1 2026.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #582 holding.
  • Optiver Holding first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2021 and has held it in 15 quarters since.
  • Optiver Holding's Lakefront Biotherapeutics American Depositary Shares position peaked at $17.4M in Q2 2022.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.